Cargando…
Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
BACKGROUND: Chemotherapy-induced peripheral neuropathy represents a major impairment to the quality of life of cancer patients and is one of the most common dose-limiting adverse effects of cancer treatment. Despite its prevalence, no effective treatment or prevention strategy exists. We have previo...
Autores principales: | Acklin, Scarlett, Sadhukhan, Ratan, Du, Wuying, Patra, Mousumi, Cholia, Ravi, Xia, Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297957/ https://www.ncbi.nlm.nih.gov/pubmed/35875690 http://dx.doi.org/10.1093/noajnl/vdac101 |
Ejemplares similares
-
Depletion of senescent-like neuronal cells alleviates cisplatin-induced peripheral neuropathy in mice
por: Acklin, Scarlett, et al.
Publicado: (2020) -
SIRT2 promotes murine melanoma progression through natural killer cell inhibition
por: Zhang, Manchao, et al.
Publicado: (2021) -
The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment
por: Acklin, Scarlett, et al.
Publicado: (2021) -
Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice
por: Trammell, Samuel A.J., et al.
Publicado: (2016) -
SUPPLEMENTATION WITH NICOTINAMIDE RIBOSIDE ATTENUATES T CELL EXHAUSTION AND IMPROVES SURVIVAL IN SEPSIS
por: Zhao, Guang-ju, et al.
Publicado: (2023)